✦ LIBER ✦

0152 Dose-dense nab-paclitaxel vs paclitaxel with bevacizumab following adriamycin and cytoxan is safe as adjuvant therapy in patients with early-stage breast cancer

✍ Scribed by J. Pippen; D. Paul; D. Richards; P. Bhar; J. Iglesias

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

0151 Adjuvant dose-dense adriamycin plus

✍ J. Pippen; J. O'Shaughnessy; S. Ambro; L. Krekow; C. Stokoe; P. Bhar; J. Iglesia 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Dose-dense doxorubicin and cyclophospham

✍ John Pippen; Devchand Paul; Svetislava Vukelja; Alicia Clawson; Jose Iglesias 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 417 KB

Adjuvant dose-dense doxorubicin plus cyc

✍ Nicholas Robert; Lea Krekow; Chris Stokoe; Alicia Clawson; Jose Iglesias; Joyce 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 199 KB

Motor dominant neuropathy induced by adj

✍ Hajime Hikino; Mika Kawashima; Takako Yamada; Nobuhiro Ozaki 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 181 KB

5034 Troponin I and C-reactive protein a

✍ P.G. Morris; C. Chen; N. Lin; B. Moy; S. Come; A. Abbruzzi; E. Winer; L. Norton; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB